{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:01:56Z","timestamp":1792609316126,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jacadv.2024.101435","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T07:41:30Z","timestamp":1734075690000},"page":"101435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Multimodal Fusion Artificial Intelligence Model to Predict Risk for MACE and Myocarditis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy"],"prefix":"10.1016","volume":"4","author":[{"given":"Chadi","family":"Ayoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalith","family":"Appari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4695-8436","authenticated-orcid":false,"given":"Milagros","family":"Pereyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6155-0266","authenticated-orcid":false,"given":"Chieh-Ju","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel G.","family":"Scalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Tiseer","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima Ali","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwoong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavik N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Arsanjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imon","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jacadv.2024.101435_bib1","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2019.07.079","article-title":"Cardiovascular toxicities of immune checkpoint inhibitors: JACC review topic of the week","volume":"74","author":"Ball","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2024.101435_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu Rev Pathol"},{"issue":"16","key":"10.1016\/j.jacadv.2024.101435_bib3","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.jacadv.2024.101435_bib4","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1161\/CIRCULATIONAHA.121.055816","article-title":"Electrocardiographic manifestations of immune checkpoint inhibitor myocarditis","volume":"144","author":"Power","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacadv.2024.101435_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40959-023-00185-y","article-title":"Complete heart block is a significant predictor of mortality in immune checkpoint inhibitor myocarditis","volume":"9","author":"O'Shea","year":"2023","journal-title":"Cardio-Oncology"},{"issue":"2","key":"10.1016\/j.jacadv.2024.101435_bib6","article-title":"Atrial and ventricular arrhythmias with immune checkpoint inhibitor therapy in patients without evidence of myocarditis","volume":"44","author":"Heemelaar","year":"2023","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.jacadv.2024.101435_bib7","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/CIRCULATIONAHA.120.049981","article-title":"Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque","volume":"142","author":"Drobni","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jacadv.2024.101435_bib8","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0735-1097(23)02571-8","article-title":"Association between immune checkpoint inhibitors with atherosclerotic plaque progression and cardiovascular events in female patients with cancer","volume":"81","author":"Suero-Abreu","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacadv.2024.101435_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.jacadv.2024.101435_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur Heart J"},{"issue":"41","key":"10.1016\/j.jacadv.2024.101435_bib11","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic Radiology and oncology (ESTRO) and the International cardio-oncology society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacadv.2024.101435_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.034497","article-title":"Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology","volume":"140","author":"Bonaca","year":"2019","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.jacadv.2024.101435_bib13","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jacc.2022.08.743","article-title":"Advances in multimodality imaging in cardio-oncology state-of-the-art review","volume":"80","author":"Baldassarre","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacadv.2024.101435_bib14","first-page":"50","article-title":"The role of artificial intelligence in echocardiography","volume":"9","author":"Barry","year":"2023","journal-title":"J\u00a0Imaging"},{"issue":"7","key":"10.1016\/j.jacadv.2024.101435_bib15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41569-020-00503-2","article-title":"Artificial intelligence-enhanced electrocardiography in cardiovascular disease management","volume":"18","author":"Siontis","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"21","key":"10.1016\/j.jacadv.2024.101435_bib16","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.jacc.2017.03.571","article-title":"Artificial intelligence in precision cardiovascular medicine","volume":"69","author":"Krittanawong","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacadv.2024.101435_bib17","article-title":"Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach","volume":"9","author":"Heilbroner","year":"2021","journal-title":"J\u00a0Immunother Cancer"},{"issue":"9","key":"10.1016\/j.jacadv.2024.101435_bib18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacadv.2024.101435_bib19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41746-020-00341-z","article-title":"Fusion of medical imaging and electronic health records using deep learning: a systematic review and implementation guidelines","volume":"3","author":"Huang","year":"2020","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.jacadv.2024.101435_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neunet.2017.07.002","article-title":"Error bounds for approximations with deep ReLU networks","volume":"94","author":"Yarotsky","year":"2017","journal-title":"Neural Netw"},{"key":"10.1016\/j.jacadv.2024.101435_bib21","series-title":"Proceedings of the ACM Conference on Health, Inference, and Learning","first-page":"40","article-title":"CaliForest: calibrated random forest for health data","author":"Park","year":"2020"},{"issue":"13","key":"10.1016\/j.jacadv.2024.101435_bib22","article-title":"Review of the immune checkpoint inhibitors in the context of cancer treatment","volume":"12","author":"Alturki","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"10124","key":"10.1016\/j.jacadv.2024.101435_bib23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(18)30533-6","article-title":"Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis","volume":"391","author":"Moslehi","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jacadv.2024.101435_bib24","article-title":"Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis","volume":"9","author":"Puzanov","year":"2021","journal-title":"J\u00a0Immunother Cancer"},{"issue":"24","key":"10.1016\/j.jacadv.2024.101435_bib25","article-title":"Immune checkpoint inhibitors-associated myocarditis: diagnosis, treatment and current status on rechallenge","volume":"12","author":"Frascaro","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"9","key":"10.1016\/j.jacadv.2024.101435_bib26","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S1470-2045(18)30457-1","article-title":"Immune checkpoint inhibitors and cardiovascular toxicity","volume":"19","author":"Lyon","year":"2018","journal-title":"Lancet Oncol"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X24007154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X24007154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T17:48:00Z","timestamp":1739641680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X24007154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2772963X24007154"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.101435","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal Fusion Artificial Intelligence Model to Predict Risk for MACE and Myocarditis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.101435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101435"}}